Ebstein-Bar Virus (EBV)-Positive diffuse large B-cell vitreoretinal lymphoma: Two cases without overt immunocompromise and review of the literature
Vitreoretinal lymphoma (VRL) remains a challenging diagnosis. EBV-positive LBCL-VR is an exceedingly rare entity with distinctive demographic and immunologic features. In addition to overt immunocompromise, immunosenescence may also be associated with EBV-positive LBCL-VR. EBV status should be evaluated in all cases of LBCL-VR, especially in LBCL without mutations in <i>MYD88</i> and/or <i>CD79a</i>.
Authors
- Jordan D. Deaner (ORCID: https://orcid.org/0000-0002-3899-4456)
- Tatyana Milman (ORCID: https://orcid.org/0000-0003-4015-7195)
- Sidra Zafar (ORCID: https://orcid.org/0000-0002-9179-2837)
- Ari H. August
Institutions
- Thomas Jefferson University (US)
- Jack Miller Center (US)
- Wills Eye Hospital (US)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2025-10-15
- DOI
- https://doi.org/10.1016/j.ajoc.2025.102453
- Citations
- 1
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.39